Continuous versus intermittent infusion of high-dose meropenem in critically ill patients: an observational cohort

Felix Bergmann1, Marlene Prager1, Katarina Kumpf2

  • 1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.

Abstract

Insights

High-dose meropenem infusion strategies for critically ill patients were compared. Continuous infusion did not show improved outcomes over intermittent infusion for 90-day mortality or secondary endpoints.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pharmacology

Background:

  • The optimal administration of high-dose meropenem in critically ill patients is debated.
  • Continuous versus intermittent infusion strategies require further clinical evaluation.

Purpose of the Study:

  • To compare the efficacy of continuous infusion versus intermittent infusion of high-dose meropenem in critically ill patients.

Main Methods:

  • A retrospective, propensity score-matched cohort study included critically ill patients receiving high-dose meropenem (6 g/day or 4 g/day).
  • Patients were matched 1:3 based on propensity scores, with 90-day all-cause mortality as the primary outcome.

Main Results:

  • Matched cohorts included 199 continuous-infusion and 597 intermittent-infusion patients.
  • Adjusted 90-day mortality was 39.5% for continuous infusion and 35.9% for intermittent infusion (p=0.33).
  • No significant differences were found in secondary outcomes, including 30-day mortality and carbapenem resistance.

Conclusions:

  • Continuous infusion of high-dose meropenem was not associated with improved clinical outcomes compared to intermittent infusion in this critically ill cohort.
  • Current evidence does not support a change in meropenem administration protocols for critically ill patients based on infusion method.

Related Concept Videos

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
333
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
315
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
616
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.7K
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.5K